The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
End-of-life (EOL) outcomes and healthcare utilization for patients with hepatocellular carcinoma (HCC) who received immune checkpoint inhibition (ICI).
 
Margaret Wheless
No Relationships to Disclose
 
Anna-Carson Uhelski
No Relationships to Disclose
 
Sarah Cimino
No Relationships to Disclose
 
Henry Domenico
No Relationships to Disclose
 
Sara Martin
No Relationships to Disclose
 
Mohana Karlekar
No Relationships to Disclose
 
Thatcher Heumann
Honoraria - Total Health
Consulting or Advisory Role - AstraZeneca; Eisai; Elevar Therapeutics; Primum
Travel, Accommodations, Expenses - Eisai
 
Kristen Ciombor
Consulting or Advisory Role - Agenus; ALX Oncology; Bayer; Exelixis; Incyte; Merck; Pfizer; Taiho Oncology; Tempus
Research Funding - Abbvie (Inst); Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Incyte (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Nucana (Inst); Onyx (Inst); Pfizer (Inst); Pfizer/Calithera (Inst); Sanofi (Inst); Seagen (Inst); Syndax (Inst)
Travel, Accommodations, Expenses - Incyte; Tempus
 
Laura Goff
Consulting or Advisory Role - AstraZeneca; Athenum Consulting; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Exelixis; Jazz Pharmaceuticals; Merck; QED Therapeutics; Relay Therapeutics
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); Basilea (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
 
Rajiv Agarwal
Honoraria - HMP Education; NCCN; OncLive/MJH Life Sciences